Clinical Trials Directory

Trials / Completed

CompletedNCT03037827

The Effect of Laser Power and Fiber Traction Speed on the Outcomes of Endovenous Laser Ablation

Three Different Regimens of Endovenous Laser Ablation With Equal Linear Endovenous Energy Density (The SLEDGE Study): a Prospective, Randomized Multicenter Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
203 (actual)
Sponsor
Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A multicenter clinical randomized controlled trial, comparing of three different regimens of endovenous laser ablation with equal linear endovenous energy density in patients with insufficiency of the great saphenous vein (GSV). The linear endovenous energy density (LEED) is the main value for standardization EVLA. From many studies, it is known the optimum value of the LEED. However, the same LEED may be obtained by varying the ratio between the laser power and the fiber pullback speed. Power decrease can allow to reduce the incidence of adverse effects of endovenous laser ablation, but keep high efficiency.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndovenous laser ablation (EVLA)Endovenous laser ablation with laser wavelength 1470 nm and radial laser fiber
DEVICELaserDevice for endovenous laser ablation manufactured by Biolitec AG company (ELVeS system) - diode laser with a wavelength of 1470 nm

Timeline

Start date
2017-01-30
Primary completion
2021-05-19
Completion
2021-05-19
First posted
2017-01-31
Last updated
2021-05-20

Locations

2 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT03037827. Inclusion in this directory is not an endorsement.